The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma Jian SunHong-Mei XuLun-Xiu Qin Original Paper 11 July 2009 Pages: 1 - 7
Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma Chunling ZhaoLei GongLimei Chen Original Paper 02 July 2009 Pages: 9 - 16
Frequent methylation of RASSF1A in synovial sarcoma and the anti-tumor effects of 5-aza-2′-deoxycytidine against synovial sarcoma cell lines Kunihiko NumotoAki YoshidaToshifumi Ozaki Original Paper 04 July 2009 Pages: 17 - 25
The prognostic role of phospho-Src family kinase analysis in tongue cancer Ofer Ben-IzhakVictoria Cohen-KaplanRafael M. Nagler Original Paper 30 June 2009 Pages: 27 - 34
Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer Chien-Ying LiuYu-Min WangHan-Pin Kuo Original Paper 02 July 2009 Pages: 35 - 45
Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis Jeong-Eun KimJi Man HanJong-Ik Hwang Original Paper 02 July 2009 Pages: 47 - 53
Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database Orlando Guntinas-LichiusThomas WendtAnnelore Altendorf-Hofmann Original Paper 01 July 2009 Pages: 55 - 63
Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma Takeshi HaraHisashi TsurumiHisataka Moriwaki Original Paper 10 July 2009 Pages: 65 - 70
Level of education and the risk of lymphoma in the European prospective investigation into cancer and nutrition Silke HermannSabine RohrmannElio Riboli Original Paper 07 July 2009 Pages: 71 - 77
The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer Dirk O. BauerschlagChristian SchemIvo Meinhold-Heerlein Original Paper 16 July 2009 Pages: 79 - 88
Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas Hendrik Andreas WolffRalph M. W. RödelHans Christiansen Original Paper Open access 18 July 2009 Pages: 89 - 97
Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen John McLaughlinVadim MarkovtsovYasumichi Hitoshi Original Paper 17 July 2009 Pages: 99 - 113
A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines George OrphanosAthanasios AlexopoulosGerassimos Rigatos Original Paper 12 August 2009 Pages: 115 - 121
Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes MLH1 and MSH2 Beate BetzStephan TheissBrigitte Royer-Pokora Original Paper 08 August 2009 Pages: 123 - 134
Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer Yuan-Yu WangZai-Yuan YeShu-Guang Li Original Paper 02 August 2009 Pages: 135 - 141
The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition Kyung-Chae JeongKyung-Ohk AhnSoo-Youl Kim Original Paper 05 August 2009 Pages: 143 - 150
Current status and developments in diagnosis and therapy of multiple myeloma Jens HillengassKai NebenHartmut Goldschmidt Meeting Report 18 September 2009 Pages: 151 - 155
Urokinase expression in course of benign and malignant mammary lesions: comparison between nodular and healthy tissues Francesca CeccarelliAndrea FusoSigfrido Scarpa Rapid Communication 14 October 2009 Pages: 157 - 163
Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors Karin OechsleCarsten BokemeyerFriedemann Honecker Letter to the Editor 16 September 2009 Pages: 165 - 167
Erratum to: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors Karin OechsleCarsten BokemeyerFriedemann Honecker Erratum 27 October 2009 Pages: 169 - 169
Erratum to: RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China Qiang LinJunfeng GengJingde Zhu Erratum 09 October 2009 Pages: 171 - 171
